Document Detail


The effect of lacidipine on patients with mild to moderate hypertension and the effect of a combination of lacidipine and hydrochlorothiazide in the treatment of hypertension uncontrolled after four weeks of lacidipine treatment: an open study.
MedLine Citation:
PMID:  9643160     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the treatment of hypertension, some patients may go off control while still on the drugs. This occurs especially with sympathetic inhibitors and vasodilators. Lacidipine, a new calcium antagonist acts principally by vasodilatation. After a wash out period, patients with mild to moderate hypertension received 4 mg of Lacidipine for two weeks. After evaluation at two weeks, those uncontrolled received 6 mg of Lacidipine, while those controlled continued with 4 mg of Lacidipine for another two weeks. By the next evaluation, while patients continued whatever doses they were on, any one who had gone off control had 25 mg of Hydrochlorothiazide added. They were evaluated finally after another two weeks. It was found in this study that 91.3% (21/23) were controlled by the end with only Lacidipine either in 4 mg or 6 mg doses. Another 8.7% (2/23) initially controlled on Lacidipine went off control while still on the drug, and were eventually controlled by adding Hydrochlorothiazide. Some transient side effects not warranting discontinuation were encountered. It is concluded that Lacidipine is effective as monotherapy in mildly to moderately hypertensive Nigerian Africans; with good tolerance and safety profile. Where transient control is encountered, addition of a diuretic could be beneficial.
Authors:
B N Okeahialam; E I Isamade; T M Ibrahim; F I Anjorin
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  West African journal of medicine     Volume:  17     ISSN:  0189-160X     ISO Abbreviation:  West Afr J Med     Publication Date:    1998 Jan-Mar
Date Detail:
Created Date:  1998-07-09     Completed Date:  1998-07-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8301891     Medline TA:  West Afr J Med     Country:  NIGERIA    
Other Details:
Languages:  eng     Pagination:  42-6     Citation Subset:  IM    
Affiliation:
Department of Medicine, Jos University Teaching Hospital, Plateau State.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
African Continental Ancestry Group
Aged
Antihypertensive Agents / therapeutic use*
Calcium Channel Blockers / therapeutic use*
Dihydropyridines / therapeutic use*
Drug Therapy, Combination
Female
Humans
Hydrochlorothiazide / therapeutic use*
Hypertension / drug therapy*
Male
Middle Aged
Nigeria
Severity of Illness Index
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Calcium Channel Blockers; 0/Dihydropyridines; 103890-78-4/lacidipine; 58-93-5/Hydrochlorothiazide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluating the laboratory techniques used in the diagnosis of sputum-producing-patients suspected of...
Next Document:  Lysis of left ventricular thrombus with urokinase in a patient with alcohol heart disease.